Group items tagged

Market Overview: Next-generation antibody therapeutics includes the use of new improvised therapeutic antibody to form innovative medicines for treating various diseases. Next-generation antibody therapeutics is developed clinically by pharmaceutical and biotechnology companies for several diseases. The Next Generation Antibody Therapeutics Market size was worth $ XX million in 2018 and is forecasted to reach $ XX million by 2026, expected to grow at a high CAGR during the forecast period 2019-2026. Market Dynamics: The Next Generation Antibody Therapeutics Market is growing due to several factors such as rising incidence of chronic diseases, increasing emergence of antibody technology, new drug discovery, large number of government initiatives, and growing research and development activities for new therapies. Rising prevalence of chronic disease such as cancer, asthma, diabetes and COPD are boosting the growth of the next generation antibody therapeutics market. For instance, according to National Cancer Institute in 2018, in United States, an estimated 1,735,350 new cases of cancer will be diagnosed and 609,640 people will die from the disease. The development of next-generation monoclonal antibodies has expanded beyond oncology into all therapeutic areas. For instance, ADCs were initially focused primarily on cancer, but Genentech has applied to infectious diseases, leading to the discovery and development of THIOMAB antibiotic conjugates (TACs) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). The technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, hence, driving the growth in the next-generation antibody therapeutics market. However, stringent government regulation, high cost and time required for research and development activities are some of the factors hindering the growth for global next-generation antibody therapeutics market. Market Segmentation: Based o

"I want to lose weight," "I will not smoke," "I will not burp in public." Witty, funny or serious, what's your New Year Resolution like? Share with us and win prizes. https://www.facebook.com/MaxHealthcareHospitals?sk=app_294889870557875

Preparing to welcome a new member in the family? It's time for both anxiety and anticipation and new parents have a lot of questions hounding them all the time. So who can answer your questions better than someone who has delivered a few hundred babies!!! Join an interactive session with our experts during the Antenatal classes and benefit from the experiences shared.

During a press conference at Max Super Speciality Hospital Saket, Yuvraj's Oncologist Dr Nitish Rohatgi says we won't miss Yuvi on field for too long! Watch video - http://www.ndtv.com/video/player/news/yuvrajs-cancer-fully-curable-can-resume-training-in-ten-weeks-doctor/223133

Here's an interesting article on Yuvraj Singh that tracks his childhood, his cricketing and his life after Cancer. One read, and you will know why we have named our campaign Yuvi… the fighter. Read it on http://www.maxhealthcare.in/aboutus/news/images/14-2-2012_outlook_national_delhi_dr_niteesh_rohtagi_2012-02-22_04-50-27.pdf. Share with your friends and let them also take a closer look at Yuvraj Singh's life and his fighter instincts.

Institute of Laboratory Medicine Max Healthcare Institute Ltd. Cordially invites you to National Conference On Advances in Coagulation and Thrombosis(Lab and Clinical Perspective) on Friday 2'nd March, 2012 at The Auditorium Max Super Speciality Hospital(West Block) Saket, New Delhi.

how to take care of skin and overall appearance in the season of spring. Your skin care regimen needs a boost with the new season. Here is how to move on from winter to spring with fresh, fabulous skin https://www.facebook.com/note.php?note_id=10150667849284870

A guide to a healthy you! Visit our new microsite dedicated to Minimal Access Metabolic and Bariatric Surgery (MAMBS) and learn all that you must know about obesity procedures, hernia, fistula, piles and much more.

For every new mother,Breastfeeding can be an enjoyable, rewarding and a successful experience and no one but your baby benefits more from this.

See how Dr Albert Matalon, a Nephrologist from Manhattan - New York, is able to practice medicine the way he likes with CureMD - something which was not possible with his previous EHR vendor. With CureMD he is able to see patients, do Medical billing (http://bit.ly/1uzfXzV) and charting seamlessly. Read more:http://www.curemd.com/testimonials.asp

Market Overview: Skin substitutes are natural, synthetic or biosynthetic materials, used to cover large wounds to restore at least some of the functions of the skin. Skin substitutes provides temporary or permanent wound closure and protect the wound from infection, further damage and water loss, and reduce pain. They also facilitate the growth of the normal skin over the wound. Skin substitutes provide a permanent solution and are used in the treatment of conditions like burns, trauma wounds, diabetes or venous ulcers, where skin grafts may not be possible. Market Dynamics: Rising chronic skin diseases is expected to drive the skin substitutes market. For instance, according to the global burden of disease study 2013, Skin conditions contributed around 1.79% to the global disease burden. According to the World Health Organization, about 132,000 melanoma skin cancers occur each year worldwide. Thus, the rising chronic diseases is increasing the demand for skin substitutes in the forecast period. Rising prevalence of diabetes is expected to boost the market. This is owing to the risk of developing a diabetic foot ulcer over the period of time in diabetic patients. For instance, WHO has reported that the incidence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is anticipated to rise from 171 million in 2000 to 366 million in 2030. Thus, as a consequence, the prevalence of diabetes related complications are expected to increase over the forecast period. There are several limitations to the commercially available skin substitutes, like reduced vascularization, poor mechanical integrity, failure to integrate, scarring, and immune rejection. Market Segmentation: Rise in preference for acellular skin substitutes to implant-based skin surgery is expected to drive the growth of the skin substitutes market. For instance, the American Society of Plastic Surgeons in 2012, reported that

Growing up fat is no fun! Read this informative article on childhood and teenage obesity and find out the ways to tackle this rising problem.

Runny nose and bouts of cough and cold? Beware, this could mean more than just catching a cold. Runny nose may also lead to diseases that are more serious.

Search healthcare & medical job types on a full-time/Permanent, part-time/ Temporary, fellowship, contract, partnership/revenue sharing, visiting consultant, traveling nurse, Locum, Home-care nurse, Researcher, fellowships, internship.

Perzue.com is the first tech-enabled Job Portal of India, dedicated to the healthcare industry. A comprehensive healthcare job portal that helps to connect, discover, and engage with fresh and experienced talent in the industry.

Market Industry Reports (MIR) has published a new report titled "Urinalysis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2030." According to the report, the global urinalysis market is estimated to be over US$ 1.4 Bn in 2017. It is anticipated to grow at a substantial CAGR from 2019 to 2030

Market Industry Reports (MIR) has published a new report titled "IV Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2030." According to the report, the global IV Equipment market is estimated to be around US$ 10.0 Bn in 2017. It is anticipated to grow at a substantial CAGR from 2019 to 2030.